MMedication Read More Weight-Loss Injections Become Part of Pre-Wedding PreparationApril 5, 2026 HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest…
MMedication Read More Surge of generic weight-loss drugs triggers price war in IndiaApril 4, 2026 Open this photo in gallery: Obesity doctor and consultant Swati Pradhan explains the Mounjaro GLP-1 self-injectable device at…
MMedication Read More GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss?April 3, 2026 Medically reviewed by Lindsay Cook, PharmD GLP-1s are now available as pills or shots.Credit: Design by Health; Getty…
MMedication Read More GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss?April 3, 2026 Medically reviewed by Lindsay Cook, PharmD GLP-1s are now available as pills or shots.Credit: Design by Health; Getty…
MMedication Read More As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices | Industry NewsMarch 31, 2026  “It is basically in the injectable space where we have reduced the price because we have…
MMedication Read More Boston to curb insurance coverage of GLP-1 drugs for city workersMarch 26, 2026 The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
MMedication Read More Ozempic Goes Generic —But Not in the USMarch 23, 2026 A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
MMedication Read More Coming Soon: ‘Wegovy HD’March 21, 2026 Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
BBusiness Read More An interview with Novo Nordisk’s Irish boss – The Irish TimesMarch 20, 2026 Dilek Dogan Gurluk wants to know what Irish summers are like. The new general manager of Novo Nordisk’s…
MMedication Read More What to Know about the Experimental GLP-1 Drug CagriSemaMarch 18, 2026 3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…